Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Financial plays

Financial plays

Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.

Neptune's losses steepen as company nears end of recovery phase

Neptune Technologies and Bioressources absorbed a steep loss in the first quarter of its fiscal year as the company nears the end of its recovery from an explosion and fire...

IAHS: “VAT on health food supplements would be a tax on health.”

Irish 23% health tax hike: Herbals, glucosamine, coQ10, probiotics remain in firing line

Proposals to push VAT (value-added tax) on some health food supplements and teas to the maximum upper bracket of 23% will discriminate against healthful products, according to The Irish Association of Health Stores (IAHS). ...

Guest article

Does Unilever’s Slim-Fast fail signal the end of weight management as we know it?

Fourteen years after Unilever spent $2.3bn (€1.7bn) to buy Slim-Fast, it has sold up for an undisclosed sum to a private equity player. Analyst and author Julian Mellentin tracks the...

Comment

The EFSA experience – remits, scientific boxes and frustrated NGOs

The European Food Safety Authority’s (EFSA) insistence on keeping well within its scientific box is both a source of frustration and comfort for onlookers.  

How to win or lose on the functional foods market

Health matters but convenience matters more, according to a report that looked at why functional foods succeeded or failed in the market place.

Pharma players want MHRA-licensed vitamin D prescribed, not supplements

New UK guidelines for vitamin D intake in the UK should recommend that only medically licensed products are prescribed and not food supplements, according to several pharma experts.

Europeans ‘not that interested’ in protein drinks, Mintel analyst warns

Arla Foods Ingredients says women wrongly believe high protein products risk making them fat or overly muscly, as Mintel warns Europeans simply aren’t that interested in protein drinks.

LONG BEACH CONVENTION CENTER, CALIFORNIA (MAY 29-31)

Top 5 snaps from the show: Healthy Beverage and World Tea Expos

Join us on a whirlwind tour of the Healthy Beverage and World Tea Expos, as we train our lens on five rising beverage brands addressing need states from enhanced hydration...

US COMMODITIES CORNER

Amino acid balancing 'targets...the best paying components in milk'

DairyReporter.com's US dairy commodities expert John Geuss explains why the amino acid balancing of feed is "one of the most impactful emerging technologies" in the dairy sector.

How can firms make claim research successes their own, not their competitors’?

Companies have to be clever about proprietary research, and plant extracts may hold unique opportunities in this respect, according to a food and nutrition industry consultant.

CLEVER MARKETING CAN OVERCOME DIFFICULT EFSA SITUATION

Beauty meets the EU energy drinks beast…

Energy drinks that also offer beauty or weight loss benefits have a growing market in the EU despite a difficult health claims environment.

Meso-zeaxanthin is pharma and needs holistic research beyond eye health, says expert

The meso-zeaxanthin cartenoid is a synthetic, quasi pharmaceutical that needs holistic research on whole body affects, says an eye health researcher.

You talkin’ to me? The grey zone around health claims in ‘commercial communication’

How we define ‘commercial communication’ when it comes to health claims remains somewhat of a grey zone, according to a Leatherhead analyst.

DISPATCHES FROM VITAFOODS EUROPE 2014

Emotional brain food for madam, and the caffeine source for you sir

When it comes to cognitive health products, women look for emotional ‘brain food’, while men look for caffeine sources, according to a survey of German students.

DISPATCHES FROM VITAFOODS EUROPE 2014

Meso-zeaxanthin’s road to EU novel approval – blindsided by commercial interests?

The discourse around eye health carotenoid meso-zeaxanthin (MZ) has been marred by commercial interests, according to supplement firm OmniActive Health Technologies.

DISPATCHES FROM VITAFOODS Europe 2014

Sustainability? Not so focal for supplements, says palm oil firm

Sustainability is not such an important issue for the supplements industry, because of the relatively low ingredient volumes involved and a difference in industry priorities, Malaysia-based Carotech has said.

Retail positioning sports nutrition's big challenge

Establishing broad acceptance is the greatest challenge facing the sports nutrition segment today, and this hinges on the creation of local mainstream retail channels, according to one analyst. 

BASF Nutrition to hone omega-3, sell Norwegian factory and cut 260 jobs

BASF says it is honing in on its omega-3 business but will sell a recently acquired low-concentration omega-3 facility in Norway as it aims high-end.

UK FSA: "We are working to clear the backlog as quickly as possible."

UK FSA reopens novel foods doors after industry concern

The UK Food Standards Agency (FSA) has backtracked on a decision to close its doors on EU novel foods applications after stakeholder unrest at the UK government austerity driven measure. ...

UK FSA: "If you are interested in submitting a novel food dossier to the EU, we advise you to contact another EU member state..."

UK FSA closes door on novel food applications as austerity bites

The UK Food Standards Agency is no longer accepting novel food applications, a development one public policy expert says is “alarming”.

Meso-zeaxanthin safety & QC debated

Neither illegal, unnatural nor unsafe, says meso-zeaxanthin defender

Meso-zeaxanthin (MZ) proponent says a French government report on the fraudulent use of meso-zeaxanthin in eye health supplements casts unnecessary doubt on a safe and viable compound. ...

Symrise wins battle for Diana Group with €1.3bn bid

German flavours and aromas specialist Symrise has won the battle for French flavour and ingredients producer Diana, after agreeing a deal that values the firm at €1.3bn.

Lost in translation: Parlez-vous health claims?

Cross-border communication must be provided to combat the confusion caused by the 24 subtly different language versions of EU-approved health claims, as well as countless other cultural nuances, according to...

News in brief

DSM in negotiations to buy Chinese vitamin C manufacturer

DSM has ended speculation about acquiring Chinese vitamin C supplier Aland by acknowledging it is in talks with the firm, but asserts no deal has been signed.

US investment network targets European health & wellness firms

Nutrition Capital Network (NCN) is setting up shop in Europe this May at Vitafoods in Geneva and is scouting for investment opportunities in the health and wellness sector.

Key Industry Events

On demand Supplier Webinars

Vitamin E and the latest science opens
DSM Nutritional Products
All supplier webinars